Abstract

Microbial biofilms on biomaterial implants or devices are hard to eliminate by antibiotics due to their protection by exopolymeric substances that embed the organisms in a matrix, impenetrable for most antibiotics and immune-cells. Application of metals in their nanoparticulated form is currently considered to resolve bacterial infections. Gold and iron-oxide nanoparticles are widely used in different medical applications, but their utilisation to eradicate biofilms on biomaterials implants is novel. Here, we studied the effect of gold and iron oxide nanoparticles on Staphylococcus aureus and Pseudomonas aeruginosa biofilms. We report that biofilm growth was reduced at higher concentrations of gold and iron-oxide nanoparticles compared to absence of nanoparticles. Thus nanoparticles with appropriate concentration could show significant reduction in biofilm formation.

Highlights

  • Biomaterial implants and devices to support and restore functioning of body parts have become common with high success rates in terms of improved quality of life

  • Biomaterial-associated infections (BAI), of relatively low incidence, represent serious complications related to high mortality rates and high health care costs [1]

  • A major proportion of the healthcare-associated infections and costs relate to BAI

Read more

Summary

Introduction

Biomaterial implants and devices to support and restore functioning of body parts have become common with high success rates in terms of improved quality of life. Biomaterial-associated infections (BAI), of relatively low incidence, represent serious complications related to high mortality rates and high health care costs [1]. According to the studies conducted by European Centre for Disease Prevention and Control, the average prevalence of healthcare-associated infections in Europe was 7.1%; that is, approximately 4,131,000 patients were affected [2]. Costs related to healthcare-associated infection are greater than C7 billion in Europe annually [2]. A major proportion of the healthcare-associated infections and costs relate to BAI. With the average life-expectancy steadily increasing, concurrent with a nonnegotiable demand for a high quality of life, the use of biomaterials for the restoration of function will increase, including the incidence of BAI. Isolated organisms include Escherichia coli and Pseudomonas aeruginosa [4]

Objectives
Methods
Results
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.